Illumina Total Assets from 2010 to 2026
| ILMN Stock | USD 116.77 0.04 0.03% |
Total Assets | First Reported 2000-03-31 | Previous Quarter 6.2 B | Current Value 6.6 B | Quarterly Volatility 4 B |
Check Illumina financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Illumina's main balance sheet or income statement drivers, such as Depreciation And Amortization of 284.6 M, Interest Expense of 63.2 M or Total Revenue of 4.6 B, as well as many indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0 or PTB Ratio of 5.48. Illumina financial statements analysis is a perfect complement when working with Illumina Valuation or Volatility modules.
Illumina | Total Assets | Build AI portfolio with Illumina Stock |
Evaluating Illumina's Total Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Illumina's fundamental strength.
Latest Illumina's Total Assets Growth Pattern
Below is the plot of the Total Assets of Illumina over the last few years. Total assets refers to the total amount of Illumina assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Illumina books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Illumina's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 6.64 B | 10 Years Trend |
|
Total Assets |
| Timeline |
Illumina Total Assets Regression Statistics
| Arithmetic Mean | 5,939,766,088 | |
| Geometric Mean | 4,041,812,612 | |
| Coefficient Of Variation | 64.72 | |
| Mean Deviation | 2,925,749,564 | |
| Median | 5,257,000,000 | |
| Standard Deviation | 3,844,125,899 | |
| Sample Variance | 14777303.9T | |
| Range | 15.2B | |
| R-Value | 0.65 | |
| Mean Square Error | 9137811.7T | |
| R-Squared | 0.42 | |
| Significance | 0 | |
| Slope | 493,511,050 | |
| Total Sum of Squares | 236436862.8T |
Illumina Total Assets History
Other Fundumenentals of Illumina
Illumina Total Assets component correlations
Click cells to compare fundamentals
About Illumina Financial Statements
Illumina investors utilize fundamental indicators, such as Total Assets, to predict how Illumina Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 6.6 B | 4.2 B | |
| Intangibles To Total Assets | 0.55 | 0.58 |
Pair Trading with Illumina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.Moving against Illumina Stock
| 0.77 | CTE | Cryosite Earnings Call Tomorrow | PairCorr |
| 0.38 | CDT | Conduit Pharmaceuticals | PairCorr |
| 0.36 | OSL | Oncosil Medical Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Illumina Correlation against competitors. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Will Life Sciences Tools & Services sector continue expanding? Could Illumina diversify its offerings? Factors like these will boost the valuation of Illumina. Market participants price Illumina higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Illumina data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.864 | Earnings Share 5.46 | Revenue Per Share | Quarterly Revenue Growth 0.05 | Return On Assets |
Illumina's market price often diverges from its book value, the accounting figure shown on Illumina's balance sheet. Smart investors calculate Illumina's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Illumina's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.